Synthetic Biology for Chemical Production

Alexandre Zanghellini, Arzeda’s CEO, penned an overview of both the current and the future impact of synthetic biology upon the chemicals industry. It highlights the opportunities that can be opened through the simultaneous advance of several technologies- improved fermentation strategies, development of biological FABs, designer biocatalysts, and improved synthetic DNA. Arzeda is at the forefront of this movement in its leading┬ádesign technology and its ability to design new metabolic pathways to molecules that compete on cost, deliver improved performance over existing molecules, and are produced sustainably.